Proteomic profiling and functional characterization of early and late shoulder osteoarthritis

Arthritis Research and Therapy

Volumn 15, Issue 6, 2013, Pages

  Wanner, John P ^a   Subbaiah, Roopashree ^a   Skomorovska Prokvolit, Yelenna ^a   Shishani, Yousef ^a   Boilard, Eric ^b   Mohan, Sujatha ^c   Gillespie, Robert ^a   Miyagi, Masaru ^a   Gobezie, Reuben ^a,d  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LAVAL UNIVERSITY   (Canada)

^c Institute of Physical and Chemical Research   (Japan)

^d UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 18; INTERLEUKIN 6; INTERLEUKIN 8; LIVER X RECEPTOR; OXYGEN 18; PROTEINASE INHIBITOR; RETINOID X RECEPTOR;

ACUTE PHASE RESPONSE; ADULT; AGED; ARTICLE; BLOOD CLOTTING; CASE CONTROL STUDY; CLINICAL ARTICLE; COMPLEMENT SYSTEM; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FEMALE; FUNCTIONAL PROTEOMICS; HUMAN; ISOTOPE LABELING; LIPID METABOLISM; MALE; METABOLIC REGULATION; OSTEOARTHRITIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SHOULDER ARTHRITIS; SHOULDER OSTEOARTHRITIS; UPREGULATION; WOUND HEALING; CHEMISTRY; LIQUID CHROMATOGRAPHY; METABOLISM; METHODOLOGY; MIDDLE AGED; PROTEOMICS; SHOULDER; SYNOVIAL FLUID; TANDEM MASS SPECTROMETRY; WESTERN BLOTTING;

ADULT; AGED; BLOTTING, WESTERN; CHROMATOGRAPHY, LIQUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS; PROTEOMICS; SHOULDER; SYNOVIAL FLUID; TANDEM MASS SPECTROMETRY;

EID: 84887066845     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4369     Document Type: Article

References (41)

1. Cheng YJ, Hootman J, Murphy LB, Langmaid GA, Helmick CG. Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation - United States, 2007-2009. MMWR 2010, 59:1261-1265.
2. Hootman JM, Helmick GC. Projections of U.S. prevalence of arthritis and associated activity limitations. Arthritis Rheum 2006, 54:226-229.
3. Gabriel SE, Crowson CS, Campion ME, O'Fallon WM. Direct medical costs unique to people with arthritis. J Rheumatol 1997, 24:719-725.
4. United States Bone and Joint Decade The Burden of Musculoskeletal Diseases in the United States 2008, Rosemont, IL: American Academy of Orthopaedic Surgeons, United States Bone and Joint Decade.
5. Amalenei C, Caruntu ID, Giusca SE, Balan RA. Matrix metalloproteinases involvement in pathologic conditions. Rom J Morphol Embryol 2010, 51:215-228.
6. Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier JP, Fahmi H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol 2011, 7:33-42.
7. Bondeson J, Blom AB, Wainwright SD, Hughes C, Caterson B, Van den Berg WB. The role of synovial macrophages and macrophage-produced mediators in driving inflammatory and destructive responses in osteoarthritis. Arthritis Rheum 2010, 62:647-657.
8. Wang Q, Rozelle AL, Lepus CM, Scanzello CR, Song JJ, Larsen DM, Crish JM, Bebek G, Ritter SY, Lindstrom TM, Hwang I, Wong HH, Punzi L, Encarnacion A, Shamloo M, Goodman SB, Wyss-Coray T, Goldring SR, Banda NK, Thurman JM, Gobezie R, Crow M, Crow K, Holers VM, Lee DM, Robinson HW. Identification of a central role for complement in osteoarthritis. Nat Med 2011, 17:1674-1679.
9. Abramson SB, Attur M. Developments in the scientific understanding of osteoarthritis. Arthritis Res Ther 2009, 11:227.
10. Kadiyala CS, Tomechko S, Miyagi M. Perfluorooctanoic acid for shotgun proteomics. PLoS One 2010, 5:e15332.
11. Shevchenko S, Tomas H, Havlis J, Olsen JV, Mann M. In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc 2007, 1:2856-2860.
12. Eckel-Passow JE, Oberg AL, Therneau TM, Mason CJ, Mahoney DW, Johnson KL, Olson JE, Bergen HR. Regression analysis for comparing protein samples with 16O/18O stable-isotope labeled mass spectrometry. Bioinformatics 2006, 22:2739-2745.
13. Ting L, Cowley MJ, Hoon SL, Guilhaus M, Raftery MJ, Cavicchioli R. Normalization and statistical analysis of quantitative proteomics data generated by metabolic labeling. Mol Cell Proteomics 2009, 8:2227-2242.
14. Ihaka R, Gentleman RR. A language for data analysis and graphics. J Comput Graph Stat 1996, 5:299-314.
15. Smyth GK. Limma: linear models for microarray data. Bioinformatics and Computational Biology Solutions using R and Bioconductor 2005, 397-420. New York: Springer, Gentleman R, Carey V, Dudoit S, Irizarry R, Huber W, [Publisher web site] [Preprint PDF] (Published 8 August 2005).
16. Warnes GR, Bolker B, Lumley T. gplots: Various R programming tools for plotting data. R package version 2.3.2 2007
17. Ingenuity Systems. [http://www.ingenuity.com].
18. Fam H, Bryant J, Kontopoulou M. Rheological properties of synovial fluids. Biorheology 2007, 44:59-74.
19. Gurtner GC, Sabine W, Barrandon Y. Longaker: Wound repair and regeneration. Nature 2008, 453:314-321.
20. Denoblea AE, Huffman KM, Stablera TV, Kellya SJ, Hershfielda MS, McDaniela GE, Colemanb RE, Krausa VB. Uric acid is a danger signal of increasing risk for osteoarthritis through inflammasome activation. PNAS 2011, 108:2088-2093.
21. Gobezie R, Kho A, Krastins B, Sarracino DA, Thornhill TS, Chase M, Millett PJ, Lee DM. High abundance synovial fluid proteome: distinct profiles in health and osteoarthritis. Arthritis Res Ther 2007, 9:R36.
22. Ritter SY, Subbaiah R, Bebek G, Crish J, Scanzello CR, Krastins B, Sarracino D, Lopez MF, Crow MK, Aigner T, Goldring MB, Goldring SR, Lee DM, Gobezie R, Aliprantis AO. Proteomic analysis of synovial fluid from the osteoarthritic knee: comparison with transcriptome analyses of joint tissues. Arthritis Rheum 2013, 65:981-992.
23. Silverman GA, Bird PI, Carrell RW, Church FC, Coughlin PB, Gettins PG, Irving JA, Lomas DA, Luke CJ, Moyer RW, Pemberton PA, Remold-O'Donnell E, Salvesen GS, Travis J, Whisstock JC. The serpins are an expanding superfamily of structurally similar but functionally diverse proteins, evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J Biol Chem 2001, 276:33293-33296.
24. Boeuf S, Steck E, Pelttari K, Hennig T, Buneß A, Benz K, Witte D, Sültmann H, Poustka A, Richter W. Subtractive gene expression profiling of articular cartilage and mesenchymal stem cells: serpins as cartilage-relevant differentiation markers. Osteoarthr Cartil 2008, 16:48-60.
25. Troberg L, Nagase H. Proteases involved in cartilage matrix degradation in osteoarthritis. Biochim Biophys Acta 1824, 2012:133-145.
26. Tchetina EV. Developmental mechanisms in articular cartilage degradation in osteoarthritis. Arthritis 2011, 16:683970.
27. Taylor SE, Weaver M, Pitsillides AA, Wheeler BT, Wheeler-Jones CP, Shaw DJ, Smith RK. Cartilage oligomeric matrix protein and hyaluronan levels in synovial fluid from horses with osteoarthritis of the tarsometatarsal joint compared to a control population. Equine Vet J 2006, 38:502-507.
28. Lohmander LS, Saxne T, Heinegård DK. Release of cartilage oligomeric matrix protein (COMP) into joint fluid after knee injury and in osteoarthritis. Ann Rheum Dis 1994, 53:8-13.
29. El-Arman MM, El-Fayoumi G, El-Shal E, El-Boghdady I, El-Ghaweet A. Aggrecan and cartilage oligomeric matrix protein in serum and synovial fluid of patients with knee osteoarthritis. HSS J 2010, 6:171-176.
30. Pfander D, Heinz N, Rothe P, Carl H, Swoboda B. Tenascin and aggrecan expression by articular chondrocytes is influenced by interleukin 1ß: a possible explanation for the changes in matrix synthesis during osteoarthritis. Ann Rheum Dis 2004, 63:240-244.
31. Sánchez-Enríquez S, Torres-Ccarrillo NM, Vázquez-Del Mercado M, Salgado-Goytia L, Rangel-Villalobos H, Muñoz-Valle JF. Increase levels of apo-A1 and apo B are associated in knee osteoarthritis: lack of association with VEGF-460 T/C and +405 C/G polymorphisms. Rheumatol Int 2008, 29:63-68.
32. Soran N, Altindag O, Cakir H, Celik H, Demirkol A, Aksoy N. Assessment of paraoxonase activities in patients with knee osteoarthritis. Redox Rep 2008, 13:194-198.
33. Sohn DH, Sokolove J, Sharpe O, Erhart JC, Chandra PE, Lahey LJ, Lindstrom TM, Hwang I, Boyer KA, Andriacchi TP, Robinson WH. Plasma proteins present in osteoarthritic synovial fluid can stimulate cytokine production via Toll-like receptor 4. Arthritis Res Ther 2012, 14:R7.
34. Tchetverikov I, Lohmander L, Verzijl N, Huizinga TW, TeKoppele JM, Hanemaaijer R, DeGroot J. MMP protein and activity levels in synovial fluid from patients with joint injury, inflammatory arthritis, and osteoarthritis. Ann Rheum Dis 2005, 64:694-698.
35. Kaneko S, Satoh T, Chiba J, Ju C, Inoue K, Kagawa J. Interleukin-6 and interleukin-8 levels in serum and synovial fluid of patients with osteoarthritis. Cytokines Cell Mol Ther 2000, 6:71-79.
36. Orita S, Koshi T, Mitsuka T, Miyagi M, Inoue G, Arai G, Ishikawa T, Hanaoka E, Yamashita K, Yamashita M, Eguchi Y, Toyone T, Takahashi K, Ohtori S. Associations between proinflammatory cytokines in the synovial fluid and radiographic grading and pain-related scores in 47 consecutive patients with osteoarthritis of the knee. BMC Musculoskelet Disord 2011, 12:144.
37. Jikko A, Wakisaka T, Iwamoto M, Hiranuma H, Kato Y, Maeda T, Fujishita M, Fuchihata H. Effects of interleukin-6 on proliferation and proteoglycan metabolism in articular chondrocyte cultures. Cell Biol Int 1998, 22:615-621.
38. Merz D, Liu R, Johnson K, Terkeltaub R. IL-8/CXCL8 and growth-related oncogene α/CXCL1 induce chondrocyte hypertrophic differentiation. J Immunol 2003, 171:4406-4415.
39. Futani H, Okayama A, Matsui K, Kashiwamura S, Sasaki T, Hada T, Nakanishi K, Tateishi H, Maruo S, Okamura H. Relation between interleukin-18 and PGE2 in synovial fluid of osteoarthritis: a potential therapeutic target of cartilage degradation. J Immunother 2002, 1:S61-S64.
40. Martel-Pelletier J, Alaaeddine N, Pelletier JP. Cytokines and their role in the pathophysiology of osteoarthritis. Front Biosci 1999, 4:d694-d703.
41. El-Arman MM, El-Fayoumi G, El-Shal E, El-Boghdady I, El-Ghaweet A. Aggrecan and cartilage oligomeric matrix protein in serum and synovial fluid of patients with knee osteoarthritis. HSS J 2010, 6:171-176.